VANCOUVER, British Columbia, Aug. 5, 2014 (GLOBE NEWSWIRE) -- Aquinox Pharmaceuticals, Inc. ("Aquinox") (Nasdaq:AQXP), a clinical-stage pharmaceutical company discovering and developing targeted therapeutics for inflammatory disease and cancer, will report its second quarter 2014 financial results and provide a general business update on Monday, August 11, 2014 after the U.S. financial markets close. Aquinox will host a conference call and live audio webcast on Monday, August 11, 2014 at 4:45 PM (ET) / 1:45 PM (PT).
Conference Call and Webcast Details:
Date: Monday, August 11, 2014
Time: 4:45 PM (ET) 1:45 PM (PT).
Toll-free: (866) 357-7878
International: (315) 625-3088
Conference ID: 83462572
The live audio webcast may be accessed through the "Events & Presentations" page in the "Investor Relations" section of the company's website at www.aqxpharma.com.
The archived conference call will be available on Aquinox's website beginning approximately two hours after the event and will be archived and available for replay for at least 30 days after the event.
About Aquinox Pharmaceuticals, Inc.
Aquinox is a clinical stage pharmaceutical company discovering and developing novel, small molecule therapeutics targeting SH2-containing inositol-5'-phosphatase 1 ("SHIP1") for the treatment of inflammatory disease and cancer. For more information, please visit www.aqxpharma.com. CONTACT: Brendan Payne Senior Manager, Investor Relations Aquinox Pharmaceuticals, Inc. 604.629.9223 Ext. 109 email@example.com Bianca Nery Senior Account Executive MacDougall Biomedical Communications 650.339.7533 firstname.lastname@example.org
Help employers find you! Check out all the jobs and post your resume.